Dan Walters: Is this a race, or a game of chicken?
California hasn’t had a truly balanced state budget for four or maybe five years, and the current one continues to overspend its revenues.
Read more
Pinnacle Financial Partners (NYSE:PNFP) Given New $130.00 Price Target at Barclays
Pinnacle Financial Partners (NYSE:PNFP – Get Free Report) had its price target dropped by equities research analysts at Barclays from $135.00 to $130.00 in a report issued on Tuesday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s price target would indicate a
Carlyle Group (NASDAQ:CG) Price Target Cut to $69.00 by Analysts at The Goldman Sachs Group
Carlyle Group (NASDAQ:CG – Get Free Report) had its price objective lowered by equities researchers at The Goldman Sachs Group from $81.00 to $69.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the financial services provider’s stock. The Goldman
TPG (NASDAQ:TPG) Given New $55.00 Price Target at The Goldman Sachs Group
TPG (NASDAQ:TPG – Get Free Report) had its price objective reduced by investment analysts at The Goldman Sachs Group from $80.00 to $55.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. The Goldman Sachs Group’s price
Oruka Therapeutics (NASDAQ:ORKA) Price Target Raised to $78.00 at Barclays
Oruka Therapeutics (NASDAQ:ORKA – Get Free Report) had its price target increased by equities researchers at Barclays from $50.00 to $78.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s price objective suggests a potential upside
